Ordering Information

Specifications and performance

About this test

This kit is used for clinical in vitro qualitative detection of creatine kinase isoenzyme (CK-MB) in human serum/plasma/whole blood(fingertip blood/venous blood). For professional use only.Creatine kinase isoenzyme (CK-MB) is an isoenzyme of creatine kinase. Creatine kinase (CK) is a highly sensitive indicator of myocardial infarction. It can be detected in the blood of patients in the early stage when myocardial cells have not been necrotic in a large area, and can be used as a reliable diagnosis for clinical myocardial infarction. After acute myocardial infarction (AMI), CK-MB increases at 3-8 hours, peaks at 8-24 hours, and returns to normal at 48-72 hours, the pattern of rise and fall indicates for myocardial injury. During myocardial infarction, serum CK-MB levels increase to 10-25 times the normal level. Therefore, the detection of CK-MB can provide a basis for physicians in the early diagnosis of AMI

The product only requires 3 drops of core/plasma or 2 drops of whole blood. If it is 3 drops of core/plasma, no sample solution is added. If it is 2 drops of whole blood, add 1 drop of sample solution, mix and drip into the sample hole, and read in 10 minutes. Results are valid within 15 minutes

Fast and easy to use

Positive: Red bands appear in both the test area (T) and the quality control area (C) , indicating a valid positive result. The color of the strip in the test area (T) can be dark or light, and all are positive results.

Negative: There is no red band appears in the test area (T), and a red band appears in the quality control area (C).

Invalid: If there is no band in the control area (C) , Regardless of whether there is a band in the test area (T), the test result is invalid. The test needs to be repeated.

Operation Suggestions

1. This product is a single-use in vitro diagnostic product, please use it within the validity period.

2. The test results of this product are for clinical reference, and should not be used as the only basis for clinical diagnosis and treatment. The clinical management of patients should be comprehensively considered in combination with their symptom.

s/signs, medical history, other laboratory tests, treatment responses, and epidemiology.

3. Users should read the Instructions for use carefully before operation, and carry out the test operation strictly in accordance with the kit instructions.

4. Wear disposable gloves when handling kits and samples, and wash hands horo ughly after handling.

5. All samples and wastes should be treated as sources of infection, The waste disposal is carried out in accordance with the relevant local regulations, please handle with care.

Operation Flow